CompositionTeneliglip M 500 Tablet PR is a combination medicine used to treat adults with type 2 diabetes mellitus. It is prescribed when blood sugar control remains inadequate with single-agent therapy, diet, and exercise. Keeping blood sugar within target ranges is essential to prevent long-term diabetic complications, including kidney damage, loss of vision, nerve problems, and cardiovascular disease.
This medicine combines teneligliptin, a DPP-4 inhibitor, with metformin, a biguanide. Metformin improves tissue response to insulin and reduces glucose formation in the liver, while teneligliptin promotes insulin secretion after meals. Swallow the tablet whole with food as prescribed to reduce stomach upset. Do not crush or chew prolonged-release tablets. Continue taking your treatment regularly even when feeling well.
Adopting a structured diabetes management plan—including a balanced diet with controlled carbohydrate intake, regular physical exercise, maintaining a healthy weight, and routine blood glucose monitoring—supports the effectiveness of this medicine.
Tell your doctor if you have kidney or liver issues, heart conditions, or severe infections before starting treatment. Contact your doctor immediately if you experience severe abdominal pain, persistent nausea, or breathing difficulties, which can signal lactic acidosis.
